Anti-aging ingredient ready for market

Dec 16, 2006

A new anti-aging ingredient developed by university researchers in Australia may be available in skin products as soon as next year.

Known as GGC, the ingredient is a forerunner for the anti-oxidant glutathione and has a number of possible health benefits, the University of New South Wales researchers said. Glutathione is a defense for detoxifying harmful compounds implicated in cancer, diabetes, aging and other diseases and degenerative conditions in the body.

University researchers said after nine years they developed a new, cost-effective way to manufacture GGC, which has been licensed to Biospecialties Australia.

Researchers said they expected the ingredient would be used in foods, health and beauty products, dietary supplements and anti-aging creams.

Natural dietary sources of GGC are available, including milk whey protein and garlic in diluted concentrations, researchers said. The new GGC product could allow for more effective doses.

Copyright 2006 by United Press International

Explore further: FDA approves hard-to-abuse narcotic painkiller

add to favorites email to friend print save as pdf

Related Stories

New hope for wrinkles

Dec 15, 2006

A new anti-aging ingredient developed by Australian researchers is expected to be available in skin products next year. The new additive - gamma glutamyl cysteine (GGC) - is a precursor for an effective antioxidant known ...

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

Jul 24, 2014

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

User comments : 0